These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 23824739)
21. Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress. Gonzalez Y; Aryal B; Chehab L; Rao VA Oncotarget; 2014 Mar; 5(6):1526-37. PubMed ID: 24681637 [TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination. Hast BE; Goldfarb D; Mulvaney KM; Hast MA; Siesser PF; Yan F; Hayes DN; Major MB Cancer Res; 2013 Apr; 73(7):2199-210. PubMed ID: 23382044 [TBL] [Abstract][Full Text] [Related]
23. Selenite cataracts: activation of endoplasmic reticulum stress and loss of Nrf2/Keap1-dependent stress protection. Palsamy P; Bidasee KR; Shinohara T Biochim Biophys Acta; 2014 Sep; 1842(9):1794-805. PubMed ID: 24997453 [TBL] [Abstract][Full Text] [Related]
24. The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner. Meng J; Majidi M; Fang B; Ji L; Bekele BN; Minna JD; Roth JA PLoS One; 2013; 8(10):e77067. PubMed ID: 24146957 [TBL] [Abstract][Full Text] [Related]
25. Akt inhibitors MK-2206 and nelfinavir overcome mTOR inhibitor resistance in diffuse large B-cell lymphoma. Petrich AM; Leshchenko V; Kuo PY; Xia B; Thirukonda VK; Ulahannan N; Gordon S; Fazzari MJ; Ye BH; Sparano JA; Parekh S Clin Cancer Res; 2012 May; 18(9):2534-44. PubMed ID: 22338016 [TBL] [Abstract][Full Text] [Related]
26. Selenium supplementation of lung epithelial cells enhances nuclear factor E2-related factor 2 (Nrf2) activation following thioredoxin reductase inhibition. Tindell R; Wall SB; Li Q; Li R; Dunigan K; Wood R; Tipple TE Redox Biol; 2018 Oct; 19():331-338. PubMed ID: 30212802 [TBL] [Abstract][Full Text] [Related]
27. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC. Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013 [TBL] [Abstract][Full Text] [Related]
28. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157 [TBL] [Abstract][Full Text] [Related]
29. LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT. Kaufman JM; Amann JM; Park K; Arasada RR; Li H; Shyr Y; Carbone DP J Thorac Oncol; 2014 Jun; 9(6):794-804. PubMed ID: 24828662 [TBL] [Abstract][Full Text] [Related]
30. VAOS, a novel vanadyl complexes of alginate saccharides, inducing apoptosis via activation of AKT-dependent ROS production in NSCLC. Zhou L; Yi Y; Yuan Q; Zhang J; Li Y; Wang P; Xu M; Xie S Free Radic Biol Med; 2018 Dec; 129():177-185. PubMed ID: 30223019 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism. Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117 [TBL] [Abstract][Full Text] [Related]
32. Hypermethylation of the Keap1 gene inactivates its function, promotes Nrf2 nuclear accumulation, and is involved in arsenite-induced human keratinocyte transformation. Wang D; Ma Y; Yang X; Xu X; Zhao Y; Zhu Z; Wang X; Deng H; Li C; Gao F; Tong J; Yamanaka K; An Y Free Radic Biol Med; 2015 Dec; 89():209-19. PubMed ID: 26409248 [TBL] [Abstract][Full Text] [Related]
33. Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells. Yang L; Zahid M; Liao Y; Rogan EG; Cavalieri EL; Davidson NE; Yager JD; Visvanathan K; Groopman JD; Kensler TW Carcinogenesis; 2013 Nov; 34(11):2587-92. PubMed ID: 23843041 [TBL] [Abstract][Full Text] [Related]
34. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer. Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952 [TBL] [Abstract][Full Text] [Related]
35. Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase. Malin D; Lee Y; Chepikova O; Strekalova E; Carlson A; Cryns VL Breast Cancer Res Treat; 2021 Dec; 190(3):373-387. PubMed ID: 34553295 [TBL] [Abstract][Full Text] [Related]
36. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway. Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910 [TBL] [Abstract][Full Text] [Related]
37. Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells. Shen X; Xia Y; Lu H; Zheng P; Wang J; Chen Y; Xu C; Qiu C; Zhang Y; Xiao Z; Zou P; Cui R; Ni D Biomed Pharmacother; 2024 May; 174():116507. PubMed ID: 38565059 [TBL] [Abstract][Full Text] [Related]
38. Selenium-independent antioxidant and anti-inflammatory effects of thioredoxin reductase inhibition in alveolar macrophages. Staples S; Wall SB; Li R; Tipple TE Life Sci; 2020 Oct; 259():118285. PubMed ID: 32798556 [TBL] [Abstract][Full Text] [Related]
39. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Solis LM; Behrens C; Dong W; Suraokar M; Ozburn NC; Moran CA; Corvalan AH; Biswal S; Swisher SG; Bekele BN; Minna JD; Stewart DJ; Wistuba II Clin Cancer Res; 2010 Jul; 16(14):3743-53. PubMed ID: 20534738 [TBL] [Abstract][Full Text] [Related]
40. Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines. Li H; Zhou S; Li X; Wang D; Wang Y; Zhou C; Schmid-Bindert G Cancer Biother Radiopharm; 2013 Mar; 28(2):115-23. PubMed ID: 23270470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]